Search
for
Sort by
Research 61–90 of 262
- A review on traditional uses, phytochemistry and pharmacology of Eclipta prostrata (L.) L.
- The safety of 52 weeks of oral DHEA therapy for postmenopausal women
- Serum Levels of Retinol-Binding Protein 4 and Adiponectin in Women with Polycystic Ovary Syndrome: Associations with Visceral Fat But No Evidence for Fat Mass-Independent Effects on Pathogenesis in This Condition
- The investigation of insulin resistance and metabolic syndrome in male patients with early-onset androgenetic alopecia
- Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess
- Polycystic Ovarian Syndrome: Long-Term Health Consequences
- Experimental and Clinical Pharmacology of<i>Ziziphus jujuba</i>Mills
- Cardiovascular risk factors and events in women with androgen excess
- Lichen planus and dyslipidemia: a systematic review and meta-analysis of observational studies
- Serum lipocalin-2 as an insulin resistance marker in patients with polycystic ovary syndrome
- Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome
- Current Perspectives on the Physiological Activities of Fermented Soybean-Derived Cheonggukjang
- Adverse health effects of androgen use
- An update review on Hibiscus rosa sinensis phytochemistry and medicinal uses
- Friends Turned Foes: Angiogenic Growth Factors beyond Angiogenesis
- Group IID, IIE, IIF and III secreted phospholipase A2s
- Oral glucose tolerance test significantly impacts the prevalence of abnormal glucose tolerance among Indian women with polycystic ovary syndrome: lessons from a large database of two tertiary care centers on the Indian subcontinent
- Cross-sex hormone therapy for gender dysphoria
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- Decreased lipin 1β expression in visceral adipose tissue is associated with insulin resistance in polycystic ovary syndrome
- Genetic basis of polycystic ovary syndrome
- Chapter 17. Selective androgen receptor modulators (SARMs)
- Evaluation and Treatment of Gender Dysphoria to Prepare for Gender Confirmation Surgery
- Candidate SNP markers of reproductive potential are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters
- Prevalence of hyperandrogenism in Iraqi women with polycystic ovary syndrome
- Gynecologic and andrologic dermatology and the metabolic syndrome
- Targets to treat androgen excess in polycystic ovary syndrome
- Testosterone in Women: Measurement and Therapeutic Use
- Skin, a mirror reflecting diabetes mellitus: A longitudinal study in a tertiary care hospital in Gujarat
- Beyond Hormones: A Systematic Review of the Risk of Cardiovascular Diseases in Polycystic Ovary Syndrome